In previous studies, hepatic mRNA and protein levels of SHP, a target of FXR/BRD4, were not changed in patients with PBC compared with healthy subjects, but nuclear levels of SHP were substantially reduced in the patients (42). This evidence concerns the gene NR0B2 and primary biliary cholangitis.